HOTAIR Facilitates Endocrine Resistance in Breast Cancer Through ESR1/miR-130b-3p Axis: Comprehensive Analysis of mRNA-miRNA-lncRNA Network
Authors:
Open Access
- 1 August 2021
- journal article
- research article
- Published by Taylor & Francis in International Journal of General Medicine
- Vol. ume 14, 4653-4663
Abstract
Background: To summarize the regulatory role of mRNA-miRNA-lncRNA network associated with endocrine therapy resistance (ETR) in breast cancer. Methods: We analyzed the differentially expressed genes (DEGs), differentially expressed lncRNAs (DELs), and differentially expressed miRNAs (DEMs) in long-term estrogen-deprived (LTED) estrogen receptor (ER)-positive breast cancer cells (LTED MCF7) (modeling relapse on endocrine therapy) and MCF7 cells in the presence of estrogen (E2) (modeling a patient at primary diagnosis) by mining GSE120929 and GSE120930 datasets. The mRNA-miRNA-lncRNA network was constructed by multiple bioinformatic tools. The prognosis of genes from the network was validated in breast cancer patients with following systemic treatment (endocrine therapy) by GEPIA, Kaplan–Meier plotter and UALCAN database. Results: Totally, 769 DEGs, 33 DEMs, and 10 DELs were selected. The mRNA-miRNA-lncRNA network was established including 60 mRNA nodes, 6 miRNA nodes and 3 lncRNA nodes. A significant module containing 3 nodes and 3 edges was calculated based on the mRNA-miRNA-lncRNA network. The hub genes in the network are ABCG2, ESR1 and GJA1. ESR1/miR-130b-3p/HOTAIR are significantly correlated with the prognosis of breast cancer patients with endocrine therapy. Conclusion: This study provides a novel ETR-related mRNA-miRNA-lncRNA network. Further, we suggest that ESR1/miR-130b-3p/HOTAIR may be promising targets for clinical treatment of endocrine therapy-resistant breast cancer.Keywords
This publication has 34 references indexed in Scilit:
- Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient managementBreast Cancer Research, 2015
- Non-coding RNA: a new frontier in regulatory biologyNational Science Review, 2014
- Endocrine resistance in breast cancer: Current status and a perspective on the roles of miRNAs (Review)Oncology Letters, 2013
- Mechanisms of Resistance to Endocrine Therapy in Breast Cancer: Focus on Signaling Pathways, miRNAs and Genetically Based ResistanceInternational Journal of Molecular Sciences, 2012
- Epigenetic silencing of miR-130b in ovarian cancer promotes the development of multidrug resistance by targeting colony-stimulating factor 1Gynecologic Oncology, 2012
- A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?Cell, 2011
- Relevance of BCAR4 in tamoxifen resistance and tumour aggressiveness of human breast cancerBritish Journal of Cancer, 2010
- Biological determinants of endocrine resistance in breast cancerNature Reviews Cancer, 2009
- Functional Screen for Genes Responsible for Tamoxifen Resistance in Human Breast Cancer CellsMolecular Cancer Research, 2006
- Connections and Regulation of the Human Estrogen ReceptorScience, 2002